Insights into heart failure hospitalizations, management, and services during and beyond COVID-19

Sarah J Charman, Lazar Velicki, Nduka C Okwose, Amy Harwood, Gordon McGregor, Arsen Ristic, Prithwish Banerjee, Petar M Seferovic, Guy A MacGowan, Djordje G Jakovljevic, Sarah J Charman, Lazar Velicki, Nduka C Okwose, Amy Harwood, Gordon McGregor, Arsen Ristic, Prithwish Banerjee, Petar M Seferovic, Guy A MacGowan, Djordje G Jakovljevic

Abstract

Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus-2. The clinical presentation of this virus mainly manifests in the respiratory system but may also lead to severe complications in the cardiovascular system. The global burden of COVID-19 has led to an unprecedented need to gain further insight into patient outcomes, management, and clinical practice. This review aims to provide an overview of the current literature on heart failure (HF) hospitalizations, management, and care pathways for supporting patients during and beyond this pandemic. A literature review of five areas of interest was conducted and included: (i) HF hospitalization; (ii) recognizing the needs and supporting HF patients during COVID-19; (iii) supporting rehabilitation services; (iv) transitioning to a telehealth framework; and (v) the need for evidence. Patients with new-onset or existing HF are particularly vulnerable, but a significant reduction in HF hospital admissions has been reported. During these periods of uncertainty, the current care pathways for acute and elective cardiac patients have had to change with the relocation of HF services to protect the vulnerable and reduce transmission of COVID-19. Optimizing community HF services has the potential to reduce the pressures on secondary care during the recovery from this pandemic. Telemedicine and virtual health care are emerging technologies and overcome the risk of in-person exposure. Successful remote delivery of cardiac rehabilitation services has been reported during the pandemic. Delivery of a robust telehealth framework for HF patients will improve communication between clinician and patient. The reduction in HF admissions is a concern for the future and may result in unintended mortality. New-onset and current HF patients must understand their diagnosis and future prognosis and seek help and support using the appropriate platform when needed. Realigning HF services and the use of telemedicine and virtual health care has great potential but needs to be carefully understood to ensure engagement and approval in this population to overcome barriers and challenges.

Keywords: COVID-19; Heart failure; Hospitalizations; Primary care; Telemedicine.

Conflict of interest statement

Sarah J. Charman, Lazar Velicki, Nduka C. Okwose, Amy Harwood, Gordon McGregor, Arsen Ristic, Prithwish Banerjee, Petar M. Seferovic, Guy A. MacGowan, and Djordje G. Jakovljevic declare that they have no conflict of interest.

© 2020 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of the European Society of Cardiology.

References

    1. Tomasoni D, Italia L, Adamo M, Inciardi RM, Lombardi CM, Solomon SD, Metra M. COVID 19 and heart failure: from infection to inflammation and angiotensin II stimulation. Searching for evidence from a new disease. Eur J Heart Fail 2020; 22: 957–966.
    1. Lala A, Johnson KW, Januzzi JL, Russak AJ, Paranjpe I, Richter F, Zhao S, Somani S, Van Vleck T, Vaid A, Chaudhry F, De Freitas JK, Fayad ZA, Pinney SP, Levin M, Charney A, Bagiella E, Narula J, Glicksberg BS, Nadkarni G, Mancini DM, Fuster V. Prevalence and impact of myocardial injury in patients hospitalized with COVID‐19 infection. J Am Coll Cardiol 2020; 76: 533–546.
    1. Gorbalenya AE, Baker SC, Baric RS, de Groot RJ, Drosten C, Gulyaeva AA, Haagmans BL, Lauber C, Leontovich AM, Neuman BW, Penzar D, Perlman S, Poon LLM, Samborskiy DV, Sidorov IA, Sola I, Ziebuhr J. Coronaviridae Study Group of the International Committee on Taxonomy of V. The species severe acute respiratory syndrome‐related coronavirus: classifying 2019‐nCoV and naming it SARS‐CoV‐2. Nat Microbiol 2020; 5: 536–544.
    1. Bavishi C, Bonow RO, Trivedi V, Abbott JD, Messerli FH, Bhatt DL. Acute myocardial injury in patients hospitalized with COVID‐19 infection: a review. Prog Cardiovasc Dis 2020. 10.1016/j.pcad.2020.05.013
    1. Boukhris M, Hillani A, Moroni F, Annabi MS, Addad F, Ribeiro MH, Mansour S, Zhao X, Ybarra LF, Abbate A, Vilca LM, Azzalini L. Cardiovascular implications of the COVID‐19 pandemic: a global perspective. Can J Cardiol 2020; 36: 1068–1080.
    1. Du RH, Liu LM, Yin W, Wang W, Guan LL, Yuan ML, Li YL, Hu Y, Li XY, Sun B, Peng P, Shi HZ. Hospitalization and critical care of 109 decedents with COVID‐19 pneumonia in Wuhan, China. Ann Am Thorac Soc 2020; 17: 839–846.
    1. Coronavirus Resource Centre. Johns Hopkins University & Medicine [cited 26 August 2020]. (26 July 2020).
    1. Wang Y, Wang Y, Chen Y, Qin Q. Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID‐19) implicate special control measures. J Med Virol 2020; 92: 568–576.
    1. Du Y, Tu L, Zhu P, Mu M, Wang R, Yang P, Wang X, Hu C, Ping R, Hu P, Li T, Cao F, Chang C, Hu Q, Jin Y, Xu G. Clinical features of 85 fatal cases of COVID‐19 from Wuhan. A retrospective observational study. Am J Respir Crit Care Med 2020; 201: 1372–1379.
    1. Liu K, Fang YY, Deng Y, Liu W, Wang MF, Ma JP, Xiao W, Wang YN, Zhong MH, Li CH, Li GC, Liu HG. Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province. Chin Med J (Engl) 2020; 133: 1025–1031.
    1. Gao Q, Hu Y, Dai Z, Xiao F, Wang J, Wu J. The epidemiological characteristics of 2019 novel coronavirus diseases (COVID‐19) in Jingmen, Hubei, China. Medicine (Baltimore) 2020; 99: e20605.
    1. Palmieri L, Vanacore N, Donfrancesco C, Lo Noce C, Canevelli M, Punzo O, Raparelli V, Pezzotti P, Riccardo F, Bella A, Fabiani M, D'Ancona FP, Vaianella L, Tiple D, Colaizzo E, Palmer K, Rezza G, Piccioli A, Brusaferro S, Onder G. Clinical characteristics of hospitalized individuals dying with COVID‐19 by age group in Italy. J Gerontol A Biol Sci Med Sci 2020; 75: 1796–1800.
    1. Escalera‐Antezana JP, Lizon‐Ferrufino NF, Maldonado‐Alanoca A, Alarcon‐De‐la‐Vega G, Alvarado‐Arnez LE, Balderrama‐Saavedra MA, Bonilla‐Aldana DK, Rodriguez‐Morales AJ. Risk factors for mortality in patients with coronavirus disease 2019 (COVID‐19) in Bolivia: an analysis of the first 107 confirmed cases. Infez Med 2020; 28: 238–242.
    1. Böhm M, Frey N, Giannitsis E, Sliwa K, Zeiher AM. Coronavirus disease 2019 (COVID‐19) and its implications for cardiovascular care: expert document from the German Cardiac Society and the World Heart Federation. Clin Res Cardiol 2020; 27: 1–14. 10.1007/s00392-020-01656-3
    1. Petrilli CM, Jones SA, Yang J, Rajagopalan H, O'Donnell L, Chernyak Y, Tobin KA, Cerfolio RJ, Francois F, Horwitz LI. Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study. BMJ 2020; 369: m1966.
    1. Palaiodimos L, Kokkinidis DG, Li W, Karamanis D, Ognibene J, Arora S, Southern WN, Mantzoros CS. Severe obesity, increasing age and male sex are independently associated with worse in‐hospital outcomes, and higher in‐hospital mortality, in a cohort of patients with COVID‐19 in the Bronx. New York Metabolism 2020; 108: 154262.
    1. Zhao XY, Xu XX, Yin HS, Hu QM, Xiong T, Tang YY, Yang AY, Yu BP, Huang ZP. Clinical characteristics of patients with 2019 coronavirus disease in a non‐Wuhan area of Hubei Province, China: a retrospective study. BMC Infect Dis 2020; 20: 311.
    1. Ciceri F, Castagna A, Rovere‐Querini P, De Cobelli F, Ruggeri A, Galli L, Conte C, De Lorenzo R, Poli A, Ambrosio A, Signorelli C, Bossi E, Fazio M, Tresoldi C, Colombo S, Monti G, Fominskiy E, Franchini S, Spessot M, Martinenghi C, Carlucci M, Beretta L, Scandroglio AM, Clementi M, Locatelli M, Tresoldi M, Scarpellini P, Martino G, Bosi E, Dagna L, Lazzarin A, Landoni G, Zangrillo A. Early predictors of clinical outcomes of COVID‐19 outbreak in Milan. Italy Clin Immunol 2020; 217: 108509.
    1. Mehra MR, Ruschitzka F. COVID‐19 illness and heart failure: a missing link? JACC Heart Fail. 2020; 8: 512–514.
    1. Aggarwal S, Garcia‐Telles N, Aggarwal G, Lavie C, Lippi G, Henry BM. Clinical features, laboratory characteristics, and outcomes of patients hospitalized with coronavirus disease 2019 (COVID‐19): early report from the United States. Diagnosis (Berl) 2020; 7: 91–96.
    1. Liu PP, Blet A, Smyth D, Li H. The Science Underlying COVID‐19: implications for the Cardiovascular System. Circulation 2020; 142: 68–78.
    1. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, Guan L, Wei Y, Li H, Wu X, Xu J, Tu S, Zhang Y, Chen H, Cao B. Clinical course and risk factors for mortality of adult inpatients with COVID‐19 in Wuhan, China: a retrospective cohort study. Lancet 2020; 395: 1054–1062.
    1. Chen Q, Xu L, Dai Y, Ling Y, Mao J, Qian J, Zhu W, Di W, Ge J. Cardiovascular manifestations in severe and critical patients with COVID‐19. Clin Cardiol 2020;[epub ahead of print 20 June 2020]; 43: 796–802.
    1. Chen T, Wu D, Chen H, Yan W, Yang D, Chen G, Ma K, Xu D, Yu H, Wang H, Wang T, Guo W, Chen J, Ding C, Zhang X, Huang J, Han M, Li S, Luo X, Zhao J, Ning Q. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ 2020; 368: m1091.
    1. Keeley P, Buchanan D, Carolan C, Pivodic L, Tavabie S, Noble S. Symptom burden and clinical profile of COVID‐19 deaths: a rapid systematic review and evidence summary. BMJ Support Palliat Care 2020. 10.1136/bmjspcare-2020-002368
    1. Iaccarino G, Grassi G, Borghi C, Ferri C, Salvetti M, Volpe M. Age and multimorbidity predict death among COVID‐19 patients: results of the SARS‐RAS study of the Italian Society of Hypertension. Hypertension 2020; 76: 366–372.
    1. Dong N, Cai J, Zhou Y, Liu J, Li F. End‐stage heart failure with COVID‐19: strong evidence of myocardial injury by 2019‐nCoV. JACC Heart Fail 2020; 8: 515–517.
    1. Rath D, Petersen‐Uribe Á, Avdiu A, Witzel K, Jaeger P, Zdanyte M, Heinzmann D, Tavlaki E, Müller K, Gawaz MP. Impaired cardiac function is associated with mortality in patients with acute COVID‐19 infection. Clin Res Cardiol 2020; 14: 1–9. 10.1007/s00392-020-01683-0
    1. Goha A, Mezue K, Edwards P, Nunura F, Baugh D, Madu E. COVID‐19 and the heart: an update for clinicians. Clin Cardiol 2020. 10.1002/clc.23406
    1. Yang J, Zheng Y, Gou X, Pu K, Chen Z, Guo Q, Ji R, Wang H, Wang Y, Zhou Y. Prevalence of comorbidities and its effects in patients infected with SARS‐CoV‐2: a systematic review and meta‐analysis. Int J Infect Dis 2020; 94: 91–95.
    1. Inciardi RM, Adamo M, Lupi L, Cani DS, Di Pasquale M, Tomasoni D, Italia L, Zaccone G, Tedino C, Fabbricatore D, Curnis A, Faggiano P, Gorga E, Lombardi CM, Milesi G, Vizzardi E, Volpini M, Nodari S, Specchia C, Maroldi R, Bezzi M, Metra M. Characteristics and outcomes of patients hospitalized for COVID‐19 and cardiac disease in Northern Italy. Eur Heart J 2020; 41: 1821–1829.
    1. Sattar Y, Connerney M, Ullah W, Rauf H, Mamtani S, Luddington S, Alraies MC. Coronavirus disease 2019 with acute respiratory distress syndrome mimicking heart failure exacerbation: time to rethink. Cardiol Res 2020; 11: 196–199.
    1. Guo J, Wei X, Li Q, Li L, Yang Z, Shi Y, Qin Y, Zhang X, Wang X, Zhi X, Meng D. Single‐cell RNA analysis on ACE2 expression provides insights into SARS‐CoV‐2 potential entry into the bloodstream and heart injury. J Cell Physiol 2020; 235: 9884–9894.
    1. Fang L, Karakiulakis G, Roth M. Are patients with hypertension and diabetes mellitus at increased risk for COVID‐19 infection? Lancet Respir Med 2020; 8: e21.
    1. Brojakowska A, Narula J, Shimony R, Bander J. Clinical implications of SARS‐CoV‐2 interaction with renin angiotensin system: JACC review topic of the week. J Am Coll Cardiol 2020; 75: 3085–3095.
    1. Fosbøl EL, Butt JH, Østergaard L, Andersson C, Selmer C, Kragholm K, Schou M, Phelps M, Gislason GH, Gerds TA, Torp‐Pedersen C, Køber L. Association of angiotensin‐converting enzyme inhibitor or angiotensin receptor blocker use with COVID‐19 diagnosis and mortality. JAMA 2020; 324: 168–177.
    1. Mancia G, Rea F, Ludergnani M, Apolone G, Corrao G. Renin–angiotensin–aldosterone system blockers and the risk of Covid‐19. New England Journal of Medicine. 2020; 382: 2431–2440.
    1. Reynolds HR, Adhikari S, Pulgarin C, Troxel AB, Iturrate E, Johnson SB, Hausvater A, Newman JD, Berger JS, Bangalore S, Katz SD, Fishman GI, Kunichoff D, Chen Y, Ogedegbe G, Hochman JS. Renin–angiotensin–aldosterone system inhibitors and risk of Covid‐19. New England Journal of Medicine 2020; 382: 2441–2448.
    1. Thornton J. Covid‐19: how coronavirus will change the face of general practice forever. BMJ 2020; 368: m1279.
    1. McIlvennan CK, Allen LA, DeVore AD, Kaltenbach LA, Granger CB, Granger BB. Changes in care delivery for patients with heart failure during the COVID‐19 pandemic: results of a multicenter survey. J Card Fail 2020; 26: 635–636.
    1. Anker SD, Butler J, Khan MS, Abraham WT, Bauersachs J, Bocchi E, Bozkurt B, Braunwald E, Chopra VK, Cleland JG, Ezekowitz J, Filippatos G, Friede T, Hernandez AF, Lam CSP, Lindenfeld J, McMurray JJV, Mehra M, Metra M, Packer M, Pieske B, Pocock SJ, Ponikowski P, Rosano GMC, Teerlink JR, Tsutsui H, Van Veldhuisen DJ, Verma S, Voors AA, Wittes J, Zannad F, Zhang J, Seferovic P, Coats AJS. Conducting clinical trials in heart failure during (and after) the COVID‐19 pandemic: an Expert Consensus Position Paper from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). Eur Heart J 2020; 41: 2109–2117.
    1. Abraham WT, Fiuzat M, Psotka MA, O'Connor CM. Heart failure collaboratory statement on clinical trials in the landscape of COVID‐19. JACC Heart Fail. 2020; 8: 423–425.
    1. Bromage DI, Cannata A, Rind IA, Gregorio C, Piper S, Shah AM, McDonagh TA. The impact of COVID‐19 on heart failure hospitalization and management: report from a Heart Failure Unit in London during the peak of the pandemic. Eur J Heart Fail 2020; 22: 978–984.
    1. Colivicchi F, Di Fusco SA, Magnanti M, Cipriani M, Imperoli G. The impact of the coronavirus disease‐2019 pandemic and Italian lockdown measures on clinical presentation and management of acute heart failure. J Card Fail 2020; 26: 464–465.
    1. Andersson C, Gerds T, Fosbøl E, Phelps M, Andersen J, Lamberts M, Holt A, Butt JH, Madelaire C, Gislason G, Torp‐Pedersen C, Køber L, Schou M. Incidence of new‐onset and worsening heart failure before and after the COVID‐19 epidemic lockdown in Denmark: a nationwide cohort study. Circ Heart Fail 2020; 13: e007274.
    1. Bollmann A, Hohenstein S, Meier‐Hellmann A, Kuhlen R, Hindricks G. Emergency hospital admissions and interventional treatments for heart failure and cardiac arrhythmias in Germany during the Covid‐19 outbreak Insights from the German‐wide Helios hospital network. Eur Heart J Qual Care Clin Outcomes 2020; 6: 221–222.
    1. Hall ME, Vaduganathan M, Khan MS, Papadimitriou L, Long RC, Hernandez GA, Moore CK, Lennep BW, McMullan MR, Butler J. Reductions in heart failure hospitalizations during the COVID‐19 pandemic. J Card Fail 2020; 26: 462–463.
    1. Cox ZL, Lai P, Lindenfeld J. Deceases in acute heart failure hospitalizations during COVID‐19. Eur J Heart Fail 2020; 22: 1045–1046.
    1. Umapathi P, Cuomo K, Riley S, Hubbard A, Menzel K, Sauer E, Gilotra NA. Transforming ambulatory heart failure care in the COVID‐19 era: initial experience from a heart failure disease management clinic. J Card Fail 2020; 26: 637–638.
    1. Moayedi Y, Alba AC, Lee DS, Wijeysundera HC, Ross HJ. The next wave of health care strain related to COVID‐19: heart failure patients coming back in force: we must not fail them. Can J Cardiol 2020; 36: 993–994.
    1. Lazaridis C, Vlachogiannis NI, Bakogiannis C, Spyridopoulos I, Stamatelopoulos K, Kanakakis I, Vassilikos V, Stellos K. Involvement of cardiovascular system as the critical point in coronavirus disease 2019 (COVID‐19) prognosis and recovery. Hellenic J Cardiol 2020. 10.1016/j.hjc.2020.05.004
    1. George I, Salna M, Kobsa S, Deroo S, Kriegel J, Blitzer D, Shea NJ, D'Angelo A, Raza T, Kurlansky P, Takeda K, Takayama H, Bapat V, Naka Y, Smith CR, Bacha E, Argenziano M. The rapid transformation of cardiac surgery practice in the coronavirus disease 2019 (COVID‐19) pandemic: insights and clinical strategies from a centre at the epicentre. Eur J Cardiothorac Surg 2020; 667–675.
    1. Barghash MH, Pinney SP. Heart failure in the COVID‐19 pandemic: where has all New York's congestion gone? J Card Fail 2020; 26: 477–478.
    1. Reza N, DeFilippis EM, Jessup M. Secondary impact of the COVID‐19 pandemic on patients with heart failure. Circ Heart Fail 2020; 13: e007219.
    1. Neth Heart Mureddu GF, Ambrosetti M, Venturini E, La Rovere MT, Mazza A, Pedretti R, Sarullo F, Fattirolli F, Faggiano P, Giallauria F, Vigorito C, Angelino E, Brazzo S, Ruzzolini M. Cardiac rehabilitation activities during the COVID‐19 pandemic in Italy. Position Paper of the AICPR (Italian Association of Clinical Cardiology, Prevention and Rehabilitation). Monaldi Arch Chest Dis 2020; 90.
    1. Walsh MN, Ravichandran AK, Seasor E, Salerno CT. Clinical distancing of hospitalized patients with advanced heart failure and cardiac transplantation during COVID‐19. J Heart Lung Transplant 2020; 39: 730.
    1. Agostoni P, Mapelli M, Conte E, Baggiano A, Assanelli E, Apostolo A, Alimento M, Berna G, Guglielmo M, Muratori M, Susini F, Palermo P, Pezzuto B, Salvioni E, Sudati A, Vignati C, Merlino L. Cardiac patient care during a pandemic: how to reorganise a heart failure unit at the time of COVID‐19. Eur J Prev Cardiol 2020; 27: 1127–1132.
    1. Harjai KJ, Agarwal S, Bauch T, Bernardi M, Casale AS, Green S, Harostock M, Ierovante N, Mascarenhas V, Matsumura M, Nawaz Y, Scott T, Singh D, Stella JJ, Vijayaraman P, Yost G, Blankenship JC. Coronary and structural heart disease interventions during COVID‐19 pandemic: a road map for clinicians and health care delivery systems Cardiovasc Revasc Med. Washington DC; 2020. 10.1016/j.carrev.2020.06.013
    1. British Society for Heart Failure . Planned Recovery Phase of Essential Heart Failure Services during Covid‐19 Pandemic: A Position Statement from the British Society for Heart Failure. 2020.
    1. Banerjee P, Gill L, Muir V, Nadar S, Raja Y, Goyal D, Koganti S. Do heart failure patients understand their diagnosis or want to know their prognosis? Heart failure from a patient's perspective. Clin Med (Lond) 2010; 10: 339–343.
    1. Banerjee P, Watson C, Ali D. Discussing prognosis in heart failure: a questionnaire‐based study of the patient's view. JACC Heart Fail. 2018; 6: 803–804.
    1. Virani SA, Clarke B, Ducharme A, Ezekowitz JA, Heckman GA, McDonald M, Mielniczuk LM, Swiggum E, Van Spall HGC, Zieroth S. Optimizing access to heart failure care in Canada during the COVID‐19 pandemic. Can J Cardiol 2020; 36: 1148–1151.
    1. British Society for Heart Failure . Retention of Essential Heart Failure Services during COVID‐19 Pandemic: A Position Statement from the British Society for Heart Failure. London, UK; 2020.
    1. Gorodeski EZ, Goyal P, Cox ZL, Thibodeau JT, Reay RE, Rasmusson K, Rogers JG, Starling RC. Virtual visits for care of patients with heart failure in the era of COVID‐19: a statement from the Heart Failure Society of America. J Card Fail 2020; 26: 448–456.
    1. Scherrenberg M, Frederix I, De Sutter J, Dendale P. Use of cardiac telerehabilitation during COVID‐19 pandemic in Belgium. Acta Cardiol 2020. 10.1080/00015385.2020.1786625
    1. Thomas E, Gallagher R, Grace SL. Future‐proofing cardiac rehabilitation: transitioning services to telehealth during COVID‐19. Eur J Prev Cardiol 2020; 204748732092292.
    1. Moulson N, Bewick D, Selway T, Harris J, Suskin N, Oh P, Coutinho T, Singh G, Chow CM, Clarke B, Cowan S, Fordyce CB, Fournier A, Gin K, Gupta A, Hardiman S, Jackson S, Lamarche Y, Lau B, Légaré JF, Leong‐Poi H, Mansour S, Marelli A, Quraishi AUR, Roifman I, Ruel M, Sapp J, Small G, Turgeon R, Wood DA, Zieroth S, Virani S, Krahn AD. Cardiac rehabilitation during the COVID‐19 era: guidance on implementing virtual care. Can J Cardiol 2020; 36: 1317–1321.
    1. Lawler PR, Filion KB, Eisenberg MJ. Efficacy of exercise‐based cardiac rehabilitation post‐myocardial infarction: a systematic review and meta‐analysis of randomized controlled trials. American Heart Journal 2011; 162: 571–84.e2.
    1. De Filippo O, D'Ascenzo F, De Ferrari GM. Heart failure related hospitalisation and management during COVID‐19 pandemic: are we ready to reflect?—reply. Eur J Heart Fail 2020. 10.1002/ejhf.1939
    1. Shah N, Ahmed I, Nazir T. Heart failure related hospitalisation and management during COVID‐19 pandemic: are we ready to reflect? Eur J Heart Fail 2020. 10.1002/ejhf.1931
    1. Cleland JGF, Clark RA, Pellicori P, Inglis SC. Caring for people with heart failure and many other medical problems through and beyond the COVID‐19 pandemic: the advantages of universal access to home telemonitoring. Eur J Heart Fail 2020; 22: 995–998.
    1. Hill L, Beattie JM, Geller TP, Baruah R, Boyne J, Stolfo GD, Jaarsma T. Palliative care: essential support for patients with heart failure in the COVID‐19 pandemic. Eur J Cardiovasc Nurs 2020; 19: 469–472.
    1. Salzano A, D'Assante R, Stagnaro FM, Valente V, Crisci G, Giardino F, Arcopinto M, Bossone E, Marra AM, Cittadini A. Heart failure management during COVID‐19 outbreak in Italy. Telemedicine experience from a heart failure university tertiary referral centre. Eur J Heart Fail 2020; 22: 1048–1050.
    1. D'Amario D, Restivo A, Canonico F, Rodolico D, Galli M, Burzotta F, Vergallo R, Trani C, Aspromonte N, Crea F. Experience of remote cardiac care during Covid‐19 pandemic: the V‐LAP™ device in advanced heart failure. Eur J Heart Fail 2020; 22: 1050–1052.
    1. Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, Falk V, Gonzalez‐Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GM, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 2016; 37: 2129–2200.
    1. Iellamo F, Sposato B, Volterrani M. Telemonitoring for the management of patients with heart failure. Card Fail Rev 2020; 6: e07.
    1. Kirk V. Evaluation of the impact of remote titration combined with telemonitoring on the optimization of guideline directed medical therapy for patients with heart failure. MSc Thesis. Health Policy, Management and Evaluation 2020.
    1. Eurlings CGMJ, Boyne JJ, de Boer RA, Brunner‐La Rocca HP. Telemedicine in heart failure‐more than nice to have? Neth Heart J 2019; 27: 5–15.
    1. O'Connor CM. Heart failure editorial emergencies in the COVID‐19 era. JACC: Heart Failure 2020; 8: 518.
    1. Lopes RD, Macedo AVS, Silva PGM d BE, Moll‐Bernardes RJ, Feldman A, D'Andréa Saba Arruda G, de Souza AS, de Albuquerque DC, Mazza L, Santos MF, Salvador NZ, Gibson CM, Granger CB, Alexander JH, de Souza OF . Continuing versus suspending angiotensin‐converting enzyme inhibitors and angiotensin receptor blockers: impact on adverse outcomes in hospitalized patients with severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2)—the BRACE CORONA Trial. Am Heart J 2020; 226: 49–59.
    1. Ozkan J. Trying times for heart failure trials during the COVID‐19 pandemic. Eur Heart J 2020; 41: 1715.
    1. Sugimoto T, Mizuno A, Kishi T, Ito N, Matsumoto C, Fukuda M, Kagiyama N, Shibata T, Ohmori T, Oishi S, Fuse J, Kida K, Kawai F, Ishida M, Sanada S, Komuro I, Node K. Coronavirus disease 2019 (COVID‐19) information for cardiologists—systematic literature review and additional analysis. Circ J 2020; 84: 1039–1043.
    1. Long B, Brady WJ, Koyfman A, Gottlieb M. Cardiovascular complications in COVID‐19. Am J Emerg Med 2020; 38: 1504–1507.
    1. Climie RE, Marques FZ. Impact, strategies, and opportunities for early and midcareer cardiovascular researchers during the COVID‐19 pandemic. Circulation 2020; 141: 1838–1840.

Source: PubMed

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir